Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

World Health Organization, Solid Tumors, Cancer Management +17

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla et al. · The Lancet · 2012 · 2K citations · Full text

Metastatic Soft-tissue Sarcoma, Placebo-controlled Phase 3, Medicine +8

Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinoma

Sharon W. Weiss, Franz M. Enzinger · Cancer · 1982 · 1.4K citations

Unique Tumor, Tumoral Pathology, Angiogenesis +15

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Stefan Sleijfer, Isabelle Ray‐Coquard, Zsuzsa Pápai et al. · Journal of Clinical Oncology · 2009 · 674 citations · Full text

Oncology, Angiogenesis, Bone Sarcoma Group +14

Epithelioid hemangioendothelioma of the liver: A clinicopathologic and follow-up study of 32 cases

Kamal G. Ishak, Isabel A. Sesterhenn, Maj Zachary D. Goodman et al. · Human Pathology · 1984 · 483 citations

Hepatology, Follow-up Study, Hepatobiliary Tumor +5